Viewing nowElzatang Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 200500713 · Notified 2005.06.29 · Insurance code 642702570
Treatment of kidney disease in patients with hypertension or type 2 diabetes mellitus accompanied by hypertension
This medication is used for the treatment of hypertension, particularly helping to prevent and treat kidney disease in patients with type 2 diabetes who have hypertension. It controls blood pressure to reduce the risk of cardiovascular complications and is also effective in protecting kidney function. Therefore, it plays an important role in preventing kidney damage caused by hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after initiation of treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular volume For patients who may have decreased effective intravascular volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This drug may cause severe harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should not be used by pregnant women or those who may become pregnant. Patients with severe liver or kidney dysfunction, history of angioedema, or specific genetic lactose intolerance should not take this medication. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, and patients with valvular heart disease or cardiovascular diseases should use this drug with caution, and especially patients with compromised kidney function should frequently check their serum potassium levels. This medication is generally well tolerated, but side effects such as dizziness, muscle pain, lower back pain, cough, and dyspepsia may occur, and rarely angioedema, liver function abnormalities, and muscle damage may happen, necessitating immediate consultation with a physician if abnormal symptoms arise. Patients with poor liver function may have elevated drug levels, so treatment should start with a lower dose, closely observing the condition. As this drug may interact with other medications, caution is advised when taken with potassium-sparing diuretics or potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc., and it is advisable to avoid grapefruit juice. This medication is not recommended for breastfeeding women and should not be used in children under 6 years of age or in children and adolescents with severely impaired kidney function. Regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary during treatment, and if symptoms of hypotension or renal failure occur, medical assistance should be sought immediately. Keep this medication out of reach of children, and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1°C and 30°C. Proper storage helps to safely maintain the drug's efficacy.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.